The global corifollitropin alfa market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Corifollitropin alfa is a hybrid follicle stimulating hormone (FSH) molecule, which is utilized to treat infertility. The molecule when infused results in the development of a high number of metaphase II oocytes in women. The primary factor that contributes to the growth of the market is the high incidence of infertility in young population owing to several underlying causes such as polycystic ovary syndrome (PCOS) or the occurrence of blockage in the fallopian tube. As per the World Health Organization (WHO), infertility affects millions of people of reproductive age all over the globe and has an impact on their families and communities. Estimates suggest that between 48 million couples and 186 million individuals live with infertility all over the globe - as per the estimates of September 2020.

Further, a substantial growth in the number of fertility clinics, rising awareness about infertility treating hormones among the global population, coupled with the technological advancements in the healthcare sector are also likely to propel the market growth. However, high cost of infertility treatments may hinder the market growth. The improvement in corifollitropin alfa efficacy for in vitro fertilization will further boost the market growth.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Application 

o By Deployment Model

o By End-User 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Merck & Co., Inc., and Schering-Plough Corp., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Corifollitropin Alfa Market Report by Segment

By Type

    • Industrial Grade

    • Pharmaceutical Grade

By End-User

    • Hospitals

    • Laboratories

Global Corifollitropin Alfa Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa